US2007155829A1PendingUtilityA1

Agent for controlling bcl-2 expression comprising ginsenoside f1 as an active component

46
Assignee: CHO SI-YOUNGPriority: Dec 28, 2002Filed: Dec 27, 2003Published: Jul 5, 2007
Est. expiryDec 28, 2022(expired)· nominal 20-yr term from priority
Inventors:Si Young ChoEun Hee LeeSu Jung KimEui Seok ShinHui Kyoung ChangDuck Hee KimMyeong Hoon YeomKwang-Sik WoeTae Ryong LeeYoung Chul Sim
A61P 43/00A61P 39/00A61P 35/04A61P 17/16A61K 31/70A61P 17/00A61K 31/704
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to an agent for controlling Bcl-2 expression comprising ginsenoside F1 (20-O-β-D-glucopyranosyl-20(S)-protopanaxatriol) represented by the following formula 1 as an active component. [Formula 1]

Claims

exact text as granted — not AI-modified
1 . An agent for controlling Bcl-2 expression comprising ginsenoside F1 as an active component.  
     
     
         2 . The agent according to  claim 1 , wherein the Bcl-2 expression is controlled because the ginsenoside F1 controls Brn-3a expression.  
     
     
         3 . Apoptosis inhibitor comprising gensenoside F1 as an active component, which inhibits apoptosis induced by low-dose ultraviolet radiation.  
     
     
         4 . The apoptosis inhibitor according to  claim 1 , wherein the apoptosis is inhibited because the ginsenoside F1 inhibits decrease of Bcl-2 expression.  
     
     
         5 . Apoptosis promoter comprising gensenoside F1 as an active component, which promotes apoptosis induced by high-dose ultraviolet radiation.  
     
     
         6 . An agent for controlling Brn-3a expression comprising ginsenoside F1 as an active component.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.